Christopher M. Holman

University of Missouri - Kansas City School of Law

Professor of Law

5100 Rockhill Road

Kansas City, MO 64110-2499

United States

SCHOLARLY PAPERS

62

DOWNLOADS
Rank 7,385

SSRN RANKINGS

Top 7,385

in Total Papers Downloads

8,698

SSRN CITATIONS
Rank 31,868

SSRN RANKINGS

Top 31,868

in Total Papers Citations

7

CROSSREF CITATIONS

19

Scholarly Papers (62)

1.

The Impact of Human Gene Patents on Innovation and Access: A Survey of Human Gene Patent Litigation

UMKC Law Review, Vol. 76, p. 295, 2007
Number of pages: 67 Posted: 11 Feb 2008 Last Revised: 26 Mar 2013
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 1,721 (14,396)

Abstract:

Loading...

patents, gene, DNA, biologics, biotechnology, genetic testing, forensics, diagnostic testing, biomedical research, research tool, patent litigation, patent infringement

2.

Is Lilly Written Description a Paper Tiger?: A Comprehensive Assessment of the Impact of Eli Lilly and its Progeny in the Courts and Pto

Albany Law Journal of Science and Technology, Vol. 17, 2007
Number of pages: 93 Posted: 18 Oct 2006
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 674 (55,062)

Abstract:

Loading...

Eli Lilly, Enzo, Written Description, patent, biotechnology, lizardtech, Falkner, enablement, DNA, proteins

3.

Do Reverse Payment Settlements Violate the Antitrust Laws?

Santa Clara Computer and High Technology Law Journal, Vol. 23, p. 489, 2007
Number of pages: 99 Posted: 30 May 2007
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 555 (70,472)

Abstract:

Loading...

patent, hatch-waxman, generic drugs, antitrust, reverse payment, settlement, exclusion payment, pharmaceutical, paragraph IV certification

4.

Will Gene Patents Derail the Next-Generation of Genetic Technologies?: A Reassessment of the Evidence Suggests Not

80 UMKC L. REV. 563 (2012).
Number of pages: 44 Posted: 08 Feb 2012 Last Revised: 05 Apr 2013
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 408 (101,846)
Citation 3

Abstract:

Loading...

gene patents, genetic technology, genome sequencing, genetic testing, human genes, biotechnology, patents, patent law, gene patents, DNA patents, biotechnology, genetic testing, diagnostic testing, whole genome sequencing, patent thicket

5.

Gene Patents Under Fire: Weighing the Costs and Benefits

Christopher M. Holman, Gene Patents under Fire: Weighing the Costs and Benefits, book chapter in BIOTECHNOLOGY AND SOFTWARE PATENT LAW: A COMPARATIVE REVIEW ON NEW DEVELOPMENTS, edited by Emanuela Arezzo and Gustavo Ghidini, Edward Elgar Publishing (2011).
Number of pages: 28 Posted: 17 Nov 2010 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 371 (113,491)

Abstract:

Loading...

Myriad, ACLU, patents, patent law, patent eligibility, patentable subject matter, gene patents, DNA patents, biotechnology, Section 101, BRCA, genetic testing, diagnostic testing

6.

Bilski: Assessing the Impact of a Newly Invigorated Patent Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine

Christopher M. Holman, Bilski: Assessing the Impact of a Newly Invigorated Patent-Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine, 10 CURRENT TOPICS IN MEDICINAL CHEMISTRY 1937 (2010).
Number of pages: 13 Posted: 23 Jun 2009 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 370 (113,867)

Abstract:

Loading...

Patents, Biotechnology, drugs, Bilski, patent eligibility, patentable subject matter, Labcorp, personalized medicine, diagnostics

7.

Copyright for Engineered DNA: An Idea Whose Time Has Come?

Christopher M. Holman, Copyright for Engineered DNA: An Idea Whose Time Has Come, 113 W. VA. L. REV. 699 (2011).
Number of pages: 40 Posted: 17 Nov 2010 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 342 (124,276)
Citation 4

Abstract:

Loading...

Synthetic biology, biotechnology, intellectual property, copyright, patent, engineered genetic sequence, engineered DNA

8.

Protein Similarity Score: A Simplified Version of the Blast Score as a Superior Alternative to Percent Identity for Claiming Genuses of Related Protein Sequences

Santa Clara Computer & High Technology Law Journal, Vol. 21, p. 55, 2004
Number of pages: 45 Posted: 01 Oct 2006
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 308 (138,785)

Abstract:

Loading...

biotechnology, BLAST, similarity, patents, written description, enablement, percent identity, similarity score, proteins, DNA, sequence

9.

Will Gene Patents Impede Whole Genome Sequencing?: Deconstructing the Myth that 20% o the Human Genome Is Patented

Christopher M. Holman, Will Gene Patents Impede Whole Genome Sequencing?: Deconstructing the Myth That 20% of the Human Genome Is Patented, 2 IP THEORY 1 (2011).
Number of pages: 15 Posted: 25 Jul 2011 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 285 (150,414)
Citation 2

Abstract:

Loading...

patents, patent law, gene patents, DNA patents, biotechnology, genetic testing, diagnostic testing, whole genome sequencing, patent thicket

10.

Biotechnology's Prescription for Patent Reform

Review of Intellectual Property Law, Vol. 5, p. 318, 2006
Number of pages: 31 Posted: 22 Sep 2006
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 282 (152,041)

Abstract:

Loading...

biotechnology, patent, H.R. 2795, patent reform, pharmaceutical, drug, reform, smith, congress, testimony, hearing

11.

Recent Developments Affecting the Enforcement, Procurement, and Licensing of Research Tool Patents

Joshua D. Sarnoff & Christopher M. Holman, Recent Developments Affecting the Enforcement, Procurement, and Licensing of Research Tool Patents, 23 BERKELEY TECH. L.J. 1299 (2008).
Number of pages: 68 Posted: 10 Apr 2008 Last Revised: 18 Feb 2015
Joshua D. Sarnoff and Christopher M. Holman
DePaul University College of Law and University of Missouri - Kansas City School of Law
Downloads 242 (176,887)
Citation 2

Abstract:

Loading...

patent, research tool, experimental use, regulatory approval, compulsory licensing, exceptions and limitations, licensing, enforcement, patentability

12.

Learning from Litigation: What Can Lawsuits Teach Us About the Role of Human Gene Patents in Research and Innovation?

Kansas Journal of Law & Public Policy, Vol. 18, p. 215, 2009
Number of pages: 52 Posted: 01 Sep 2009 Last Revised: 30 Mar 2013
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 206 (205,984)

Abstract:

Loading...

patents, gene, DNA, biologics, biotechnology, genetic testing, forensics, diagnostic testing, biomedical research, research tool, patent litigation, patent infringement, patent thicket, anticommons, university patenting, gene patents, DNA micro-array

13.

Response to ‘Pervasive Sequence Patents Cover the Entire Human Genome’

Genome Medicine, Vol. 6, No. 14, 2014, George Mason Law & Economics Research Paper No. 14-07, San Diego Legal Studies Paper No. 14-148, Loyola-LA Legal Studies Paper No. 2014-19, Georgia State University College of Law, Legal Studies Research Paper No. 2014-16
Number of pages: 4 Posted: 01 Mar 2014 Last Revised: 14 May 2014
West Virginia University College of Law, University of Missouri - Kansas City School of Law, George Mason University - Antonin Scalia Law School, Faculty, University of San Diego School of Law, Villanova University Charles Widger School of Law, University of Utah - S.J. Quinney College of Law, Georgia State University College of Law, University of Baltimore - School of Law and Loyola Law School Los Angeles
Downloads 185 (226,631)
Citation 1

Abstract:

Loading...

gene patents, human genome, Myriad Genetics, patent claims, patent scope

14.

In Defense of Secondary Pharmaceutical Patents: A Response to the UN's Guidelines for Pharmaceutical Patent Examination

Indiana Law Review, Forthcoming
Number of pages: 56 Posted: 04 Sep 2016
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 184 (227,731)
Citation 1

Abstract:

Loading...

Secondary Pharmaceutical Patents, Guidelines for Pharmaceutical Patent Examination, Patents, Pharmaceutical Patents, Drug Patents

15.

Maintaining Incentives for Healthcare Innovation: A Response to the FTC's Report on Follow-On Biologics

Christopher M. Holman, Maintaining Incentives for Healthcare Innovation: A Response to the FTC's Report on Follow-On Biologics, 11 MINN. J.L. SCI. & TECH. 755 (2010).
Number of pages: 46 Posted: 02 Oct 2009 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 183 (228,811)

Abstract:

Loading...

follow-on biologics, biosimilars, biogenerics, biologic drugs, Hatch-Waxman, FTC, patents, biotechnology, FDA, data exclusivity

16.

Mayo, Myriad, and the Future of Innovation in Molecular Diagnostics and Personalized Medicine

Christopher M. Holman, Mayo, Myriad, and the Future of Innovation in Molecular Diagnostics and Personalized Medicine, 15 North Carolina Journal of Law and Technology 639 (2014).
Number of pages: 40 Posted: 17 Apr 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 174 (238,914)

Abstract:

Loading...

Mayo, Prometheus, gene patents, Myriad, patent eligibility, patentable subject matter, molecular diagnostics, personalized medicine

17.

The Perils of Taking Property Too Far

Stanford Journal of Law, Science and Policy, Vol. 46, 2009
Number of pages: 19 Posted: 27 May 2009 Last Revised: 14 Nov 2012
Duke Institute for Genome Sciences & Policy, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Alberta - Faculty of Public Health, University of Missouri - Kansas City School of Law, affiliation not provided to SSRN, Duke University, Fuqua School of Business-Economics Group and Arizona State University (ASU) - School for the Future of Innovation in Society
Downloads 169 (244,825)

Abstract:

Loading...

biobank, biobanks, genetic testing, genomic testing, Canavan, Myriad, BRCA, research ethics, gene patents, genes, patents, ethics, business models, public health care, clinicial genetics

18.

Developments in Synthetic Biology are Altering the IP Imperatives of Biotechnology

17 Vanderbilt J. Ent. & Tech. L. 385 (2015).
Number of pages: 78 Posted: 27 Jun 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 160 (256,427)
Citation 1

Abstract:

Loading...

Patents, intellectual property, biotechnology, synthetic biology

19.

Ajinomoto v. ITC, the Doctrine of Equivalents, and Biomolecule Claim Limitations at the Federal Circuit

Biotechnology Law Report, 2020
Number of pages: 25 Posted: 28 May 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 144 (279,124)

Abstract:

Loading...

Ajinomoto, patents, biotechnology, biomolecules, DNA, proteins, doctrine of equivalents, prosecution history estoppel

20.

Are Engineered Genetic Sequences Copyrightable?: The U.S. Copyright Office Addresses a Matter of First Impression

35 Biotechnology Law Report 103 (2016)
Number of pages: 21 Posted: 02 Oct 2016
Christopher M. Holman, Claes Gustafsson and Andrew W. Torrance
University of Missouri - Kansas City School of Law, Independent and University of Kansas School of Law
Downloads 140 (285,323)

Abstract:

Loading...

Copyright, Copyright Office, Copyright Registration, DNA Copyright, Gene Copyright, Synthetic Biology, Biotechnology, Genetic Engineering

21.

The Role of Objective Indicia in Assessing the Nonobviousness of Pharmaceutical Inventions

37 Biotechnology Law Report 4 (2018)
Number of pages: 30 Posted: 08 Feb 2019
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 125 (310,918)

Abstract:

Loading...

nonobviousness, patent, pharmaceuticals, objective indicators, objective indicia, secondary considerations

22.

Patent Eligibility Post-Myriad: A Reinvigorated Judicial Wildcard of Uncertain Effect

George Washington Law Review, Vol. 82, No. 1796, 2014
Number of pages: 36 Posted: 20 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 93 (379,696)

Abstract:

Loading...

Patent eligibility, Prometheus, Mayo, Myriad, patentable subject matter

23.

Bowman v. Monsanto Co.: A Bellwether for the Emerging Issue of Patentable Self-Replicating Technologies and Inadvertent Infringement

Missouri Law Review, Vol. 80, 2015
Number of pages: 59 Posted: 12 Feb 2016
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 84 (403,932)

Abstract:

Loading...

Patents, Self-replicating technology, DNA, biotechnology, self-replication, bowman, Monsanto, agriculture, seeds patents

24.

Caught between a Rock and a Hard Place: How Limelight Compounds the Challenges Facing Biotechnology Innovators after Mayo and Myriad

Christopher M. Holman, Caught Between a Rock and a Hard Place: How Limelight Compounds the Challenges Facing Biotechnology Innovators After Mayo and Myriad, 33 BIOTECHNOLOGY LAW REPORT 135 (2014).
Number of pages: 4 Posted: 20 Feb 2015 Last Revised: 21 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 84 (403,932)

Abstract:

Loading...

Divided infringement, joint infringement, Muniauction, Limelight, Akamai, personalized medicine, genetic testing, molecular diagnostics, induced infringement, indirect patent infringement

25.

Congress Should Decline Ill-Advised Legislative Proposals Aimed at Evergreening of Pharmaceutical Patent Protection

The University of the Pacific Law Review, 2020
Number of pages: 30 Posted: 03 Jun 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 83 (406,765)

Abstract:

Loading...

patents, pharmaceuticals, drugs, legislation, evergreening, prduct hopping, patent thicketing

26.

The Critical Role of Patents in the Development, Commercialization and Utilization of Innovative Genetic Diagnostic Tests and Personalized Medicine

Boston University journal of Science and Technology Law, Vol. 21, No. 2, 2015
Number of pages: 20 Posted: 12 Feb 2016
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 83 (406,765)

Abstract:

Loading...

patents, innovation, biotechnology, diagnostics, personalized medicine, Myriad, Mayo, Prometheus, genetics

27.

Technology Changes Drive Legal Changes for Antibody Patents: What Patent Examiners Can Teach Courts About the Written Description and Enablement Requirements

Berkeley Technology Law Journal, Forthcoming, WVU College of Law Research Paper No. 2022-005
Number of pages: 48 Posted: 10 Feb 2022 Last Revised: 06 Apr 2022
S. Sean Tu and Christopher M. Holman
West Virginia University College of Law and University of Missouri - Kansas City School of Law
Downloads 79 (418,546)

Abstract:

Loading...

patent, antibody, USPTO, PTO, written description, enablement, patent examiner, prosecution, litigation

28.

Supreme Court Asked to Consider Role of Post-Filing Evidence in Assessing Obviousness of Pharmaceutical Inventions

34 Biotechnology L. Rep. 49 (2015).
Number of pages: 4 Posted: 27 Jun 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 70 (447,354)

Abstract:

Loading...

Patents, Nonobviousness, Pharmaceutical Patents, Drug Patents

29.

Patentability Standards for Follow-On Pharmaceutical Innovation

37 BIOTECHNOLOGY LAW REPORT 131 (2018)
Number of pages: 31 Posted: 31 Jul 2018 Last Revised: 06 May 2020
Christopher M. Holman, Timo Minssen and Eric M. Solovy
University of Missouri - Kansas City School of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Sidley Austin LLP
Downloads 67 (457,691)
Citation 1

Abstract:

Loading...

UNDP, Patentability Guidelines, Patent Examination, Pharmaceutical Patents, TRIPS Agreement

30.

Charting the Contours of a Copyright Regime Optimized for Engineered Genetic Code

Oklahoma Law Review
Number of pages: 63 Posted: 04 Sep 2016
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 67 (457,691)
Citation 1

Abstract:

Loading...

Copyright, biotechnology, DNA, genetic code, synthetic biology

31.

How Real is the Concern that Seed Patents Will Turn Farmers into Inadvertent Infringers?

Christopher M. Holman, How Real Is the Concern that Seed Patents Will Turn Farmers into Inadvertent Infringers?, 33 BIOTECHNOLOGY LAW REPORT 165 (2014).
Number of pages: 6 Posted: 20 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 65 (464,707)

Abstract:

Loading...

Bowman, Monsanto, genetically modified crops, agricultural biotechnology, inadvertent infringement, inadvertent patent infringement, patent exhaustion, seed patent

32.

Patent Eligibility as a Policy Lever to Regulate the Patenting of Personalized Medicine

Christopher M. Holman, Patent Eligibility as a Policy Lever to Regulate the Patenting of Personalized Medicine, book chapter in PERSPECTIVES ON PATENTABLE SUBJECT MATTER, edited by Michael Abramowicz, F. Scott Kieff and James E. Daily, Cambridge University Press (2014).
Number of pages: 32 Posted: 20 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 62 (475,812)

Abstract:

Loading...

Patent eligibility, Prometheus, Mayo, Bilski, personalized medicine, diagnostics, diagnostic testing, molecular diagnostics, genetic testing, patentable subject matter

33.

Book Review: Patent Ethics: Prosecution, by David Hricik & Mercedes Meyers

The IP Law Book Review, Vol. 1, No. 1, pp 40-45, June 2010
Number of pages: 7 Posted: 09 Oct 2010
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 61 (479,642)

Abstract:

Loading...

Patents, Patent Law, Patent Prosecution, Patent Ethics, Legal Ethics, Professional Responsibility, PTO, Patent And Trademark Office, PTO Code of Professional Conduct, Model Rules of Professional Conduct, Model Code of Professional Responsibility

34.

Misplaced Fears in the Battle Over Affordable Biotech Drugs

50 IDEA 565 (2010)
Number of pages: 27 Posted: 21 Mar 2015
David E. Adelman, David E. Adelman and Christopher M. Holman
University of Texas School of LawUniversity of Texas at Austin - Kay Bailey Hutchison Center for Energy, Law & Business and University of Missouri - Kansas City School of Law
Downloads 50 (524,775)

Abstract:

Loading...

follow-on biologics, biogenerics, biologics, patents, FDA, health care reform

35.

Do Biotech Patent Lawsuits Really 'Overwhelmingly Lose?': A Response to Our Divided Patent System

34 Biotechnology L. Rep. 59 (2015).
Number of pages: 9 Posted: 27 Jun 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 48 (533,725)

Abstract:

Loading...

patents, biotechnology, patent litigation, patent empirical studies

36.

Unpredictability in Patent Law and Its Effect on Pharmaceutical Innovation

Missouri Law Review, Vol. 76, p. 645, 2011
Number of pages: 49 Posted: 21 Mar 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 45 (547,776)

Abstract:

Loading...

Patents, patent policy, pharmaceutical patents, drug patents, pharmaceutical innovation

37.

Antibody Claims and the Evolution of the Written Description / Enablement Requirement

IDEA: The IP Law Review, 2023, WVU College of Law Research Paper No. 2022-011
Number of pages: 42 Posted: 06 May 2022 Last Revised: 26 Jul 2022
S. Sean Tu and Christopher M. Holman
West Virginia University College of Law and University of Missouri - Kansas City School of Law
Downloads 43 (557,574)

Abstract:

Loading...

antibody, patent, USPTO, patent examination, examiner, prosecution, written description, enablement, 35 USC 112(a)

38.

Gilead Sciences Sued for Failing to Bring a Follow-on Version of Truvada to Market Sooner

Biotechnology Law Report, 2019
Number of pages: 15 Posted: 27 May 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 31 (623,745)

Abstract:

Loading...

patents, drugs, antitrust, product hopping, Gilead, Truvada

39.

The Lilly Written Description Requirement: A Doctrinal Wildcard of Uncertain Effect

Research Handbook on Patent Law & Theory (2nd Edition), ISBN: 978-1-78536-411-2, Edward Elgar, 2019
Number of pages: 33 Posted: 02 Jun 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 29 (636,465)

Abstract:

Loading...

patent, biotechnology, written description requirement, Eli Lilly, Ariad, LWD

40.

Nuvo v. Dr. Reddy and the Patentability of Prophetic Pharmaceutical Inventions Based on Unexplained Inventive Insight

Biotechnology Law Report, 2019
Number of pages: 13 Posted: 27 May 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 27 (649,908)

Abstract:

Loading...

patents, patentability, drugs, written description requirement, inventive concept, Nuvo[comma separated]

41.

Eli Lilly v. Teva: Generic Companies Infringe under Akamai IV in Case of Divided Infringement

36 BIOTECHNOLOGY LAW REPORT 31 (2017)
Number of pages: 7 Posted: 17 Aug 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 26 (656,963)

Abstract:

Loading...

patent, biotechnology, diagnostics, divided infringement, joint infringement, induced infringement, Akamai

42.

The Renewable Fuel Standard Reimagined: Clearing a Path for Truly Advanced Biofuels

86 UMKC L. Rev. 805 (2018)
Number of pages: 50 Posted: 02 Jun 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 26 (656,963)

Abstract:

Loading...

renewable fuel standard, biofuels,

43.

Helsinn v. Teva: Lingering Ambiguity after the U.S. Supreme Court Holds the AIA Did Not Alter the On-Sale Bar to Patentability

Biotechnology Law Report, 2019
Number of pages: 23 Posted: 27 May 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 24 (671,511)

Abstract:

Loading...

patents, biotechnology, pharamceuticals, on-sale bar, AIA, Helsinn

44.

A Fractured International Response to CRISPR-Enabled Gene Editing of Agricultural Products

38 Biotechnology Law Report 3 (2019).
Number of pages: 54 Posted: 22 Apr 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 24 (671,511)

Abstract:

Loading...

CRISPR, gene editing

45.

Congress Considering Legislation Aimed at Increasing Competition in Pharmaceuticals

Biotechnology Law Report, 2019
Number of pages: 15 Posted: 27 May 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 21 (694,506)

Abstract:

Loading...

patents, drugs, Congress, legislation, patent reform

46.

Recent PTO Guidance Charts a New Course Through the Patent Eligibility Quagmire

Biotechnology Law Report, 2019
Number of pages: 13 Posted: 27 May 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 20 (702,288)

Abstract:

Loading...

patent, patent eligibility, biotechnology, PTO guidance, Patent Office, PTO

47.

Praxair v. Mallinckrodt: An Expanded Interpretation of the Printed Matter Doctrine with Important Implications for Biotechnology

37 BIOTECHNOLOGY LAW REPORT 188 (2018)
Number of pages: 17 Posted: 23 Oct 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 19 (710,213)

Abstract:

Loading...

Praxair, Printed Matter Doctrine, Patent Eligibility, Patent-Ability, Biotechnology

48.

The Role of Patent Eligibility in Policing Claim Scope

1 IP Theory 56 (2011)
Number of pages: 15 Posted: 21 Mar 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 17 (726,681)

Abstract:

Loading...

Bilski, patent eligibility, patentable subject matter

49.

Branded Drug Companies are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation

40 BIOTECHNOLOGY LAW REPORT 72 (2021)
Number of pages: 34 Posted: 25 Mar 2022
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 16 (735,038)

Abstract:

Loading...

pharmaceuticals, patents, Hatch-Waxman, doctrine of equivalents

50.

The Federal Circuit Continues to Grapple with the Question of Patent Eligibility for Diagnostic Methods

40 BIOTECHNOLOGY LAW REPORT 151 (2021)
Number of pages: 37 Posted: 25 Mar 2022
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 14 (752,782)

Abstract:

Loading...

patents, diagnostics, Mayo. patent eligibility, Vanda, Ariosa

51.

Congress Considering Legislation Intended to Reverse the Recent Trend toward Devaluation of the U.S. Patent Right

37 BIOTECHNOLOGY LAW REPORT 243 (2018)
Number of pages: 12 Posted: 23 Oct 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 13 (761,937)

Abstract:

Loading...

patents, biotechnology, legislation, patent reform, patent devaluation

52.

The Supreme Court’s Devaluation of U.S. Patents

36 BIOTECHNOLOGY LAW REPORT 151 (2017)
Number of pages: 16 Posted: 21 Oct 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 13 (761,937)

Abstract:

Loading...

Sandoz, TC Heartland, Impression Products, patents, Supreme Court, biotechnology

53.

Vanda v. West-Ward Pharmaceuticals: Good News for the Patent Eligibility of Diagnostics and Personalized Medicine, with Some Important Caveats

37 BIOTECHNOLOGY LAW REPORT 117 (2018)
Number of pages: 9 Posted: 23 Oct 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 12 (771,305)

Abstract:

Loading...

Vanda, Mayo, Patent Eligibility, Biotechnology, Diagnostic Test, Patent-Ability

54.

In re Huping Hu: Quantum Entanglement, Medical Innovation, and Patentability on the Scientific 'Fringe'

40 BIOTECHNOLOGY LAW REPORT 222 (2021)
Number of pages: 23 Posted: 25 Mar 2022
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 11 (780,705)

Abstract:

Loading...

quantum entanglement, utility requirement, patent examination, inoperative inventions, incredible inventions

55.

In Minerva v. Hologic, the U.S. Supreme Court Reins in the Equitable Doctrine of Assignor Estoppel

40 BIOTECHNOLOGY LAW REPORT 294 (2021)
Number of pages: 28 Posted: 25 Mar 2022
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 10 (790,349)

Abstract:

Loading...

patents, assignor estoppel, Minerva, Hologic, Supreme Court

56.

FDA’s Efforts to Tame the 'Wild West' of Regenerative Medicine

36 BIOTECHNOLOGY LAW REPORT 217 (2017)
Number of pages: 6 Posted: 21 Oct 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 10 (790,349)

Abstract:

Loading...

regenerative medicine, FDA, regulation, stem cell treatments

57.

Government Involvement in Pharmaceutical Development Can Come Back to Haunt a Drug Company

40 BIOTECHNOLOGY LAW REPORT 4 (2021)
Number of pages: 26 Posted: 25 Mar 2022
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 8 (810,292)

Abstract:

Loading...

Pharmaceuticals, Bayh-Dole, Patents, March-in rights, Gilead

58.

A Biotechnology-Centric Look at Fee Shifting in Patent Litigation Post-Octane Fitness

36 BIOTECHNOLOGY LAW REPORT 81 (2017)
Number of pages: 4 Posted: 21 Oct 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 8 (810,292)

Abstract:

Loading...

Octane Fitness, Highmark, attorneys fees, attorney fee-shifting, patent litigation, biotechnology

59.

The Mayo Framework Is Bad for Your Health

23 George Mason Law Review 901 (2016)
Number of pages: 40 Posted: 02 Jun 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 7 (820,527)

Abstract:

Loading...

patent eligibility, patent, Mayo, biotechnology, diagnostics

60.

Trend in Human Gene Patent Litigation

Science 322:198-99 (2008)
Posted: 21 Mar 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law

Abstract:

Loading...

patent policy, patents, gene patents, patent litigation

61.

Patent Border Wars: Defining the Boundary between Scientific Discoveries and Patentable Inventions

Trends in Biotechnology, Vol. 25, pp. 539-543, 2007
Posted: 11 Feb 2008
Christopher M. Holman
University of Missouri - Kansas City School of Law

Abstract:

Loading...

patentable subject matter, research tools, genes, patents, gene patents, research tools

62.

Clearing a Path Through the Patent Thicket

Cell, Vol. 125, pp. 629-633, 2006
Posted: 18 Oct 2006 Last Revised: 17 May 2014
Christopher M. Holman
University of Missouri - Kansas City School of Law

Abstract:

Loading...

patents, biotechnology, patent thicket, research tools, research use, Bayh-Dole, upstream patents, junk patents, open source

Other Papers (4)

Total Downloads: 123
1.

Brief of Amici Curiae Interested Patent Law Professors in Support of Neither Party in Prometheus v. Mayo

Federal Circuit Court of Appeals, 2009 WL 462602
Number of pages: 28 Posted: 13 Nov 2009 Last Revised: 05 May 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 45

Abstract:

Loading...

Prometheus, Mayo, Bilski, patentable subject matter, patent eligibility, diagnostics, personalized medicine, biotechnology

2.

Brief of Amicus Curiae Law Professor Christopher M. Holman in Support of Neither Party in Ariad v. Eli Lilly

Federal Circuit Court of Appeals, 2009 WL 3711551
Number of pages: 42 Posted: 13 Nov 2009 Last Revised: 05 May 2020
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 39

Abstract:

Loading...

Ariad, Eli Lilly, biotechnology, patent law, written description requirement, amicus

3.

On the Question: Is Copyright the Way to Gain Intellectual Property Protection for DNA Sequences?

33 Biotechnology Law Report 139, 2014
Number of pages: 2 Posted: 20 Sep 2014
Christopher M. Holman and Andrew W. Torrance
University of Missouri - Kansas City School of Law and University of Kansas School of Law
Downloads 29

Abstract:

Loading...

4.

Intellectual Property in the Age of Personal Genomics and Synthetic Biology

Christopher M. Holman, Intellectual Property in the Age of Personal Genomics and Synthetic Biology, 31 BIOTECHNOLOGY LAW REPORT 1 (2012).
Number of pages: 2 Posted: 17 Apr 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 10

Abstract:

Loading...

patents, intellectual property, biotechnology, genomics, synthetic biology, genetic testing, diagnostic testing